Erratum: Sufentanil sublingual tablet system (Zalviso®) as an effective analgesic option after thoracic surgery: An observational study
Format: | Article |
---|---|
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Saudi Journal of Anaesthesia |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2020;volume=14;issue=1;spage=145;epage=145;aulast= |
Similar Items
-
Sufentanil sublingual tablet system (Zalviso®) as an effective analgesic option after thoracic surgery: An observational study
by: Costa Fabio, et al.
Published: (2019-01-01) -
Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
by: Marco Scardino, et al.
Published: (2018-03-01) -
Sublingual sufentanil (Zalviso) patient-controlled analgesia after total knee arthroplasty: a retrospective comparison with oxycodone with or without dexamethasone
by: van Veen DE, et al.
Published: (2018-12-01) -
Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study
by: Turi S, et al.
Published: (2019-07-01) -
The statistical analyses of the study “Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study”[Letter]
by: Wang X, et al.
Published: (2019-09-01)